| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000262823.1 |
Gefitinib |
Esophageal cancer |
0.004940192 |
Resistant |
| ENSG00000262823.1 |
Gefitinib |
Breast invasive carcinoma |
0.045888358 |
Sensitive |
| ENSG00000262823.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018607093 |
Sensitive |
